Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19
about
Importance of multi-p450 inhibition in drug-drug interactions: evaluation of incidence, inhibition magnitude, and prediction from in vitro dataPharmacokinetic drug interaction profiles of proton pump inhibitors: an updatePharmacogenetics in drug regulation: promise, potential and pitfalls.Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypesPharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6.Population pharmacokinetics of omeprazole in a random Iranian population.Impact of genetic polymorphism on drug-drug interactions mediated by cytochromes: a general approach.Effects of CYP2C19 Genetic Polymorphisms on PK/PD Responses of Omeprazole in Korean Healthy Volunteers.Evaluating a physiologically based pharmacokinetic model for prediction of omeprazole clearance and assessing ethnic sensitivity in CYP2C19 metabolic pathway.In vivo quantitative prediction of the effect of gene polymorphisms and drug interactions on drug exposure for CYP2C19 substratesOmeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P450 2C19 and 3A phenotyping.Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes.
P2860
Q27009128-891D1B14-4D80-42A2-BF22-55CB6B126BD8Q27022254-078ECE33-5B82-4A97-8F17-79257304C220Q35038052-97A8784F-5B99-47CD-A208-953DC492A619Q35826075-FCE46C8C-2FCB-423E-BE77-3F35A169E55FQ36365500-5AB6F005-88B9-4862-9C49-CFF201D01E03Q37128495-C9526856-703D-4A06-9FDC-2A8BE33CCCACQ37207816-CD197778-0A8E-44EE-8839-B75116F947AEQ37740439-FA2CCD5B-3AC0-4E75-BD70-1B3B59C716D6Q41174078-C6D1C5E4-C6F5-44D3-A025-CE9F632CD401Q41986948-5D695C7F-AF3F-4CB5-A339-1233D97C8B6CQ43626046-27FD8C6C-A6F9-4B14-9B86-E22C59E18FA8Q45117146-A083BD96-36A7-4B2D-86BE-287CA073B17A
P2860
Omeprazole hydroxylation is inhibited by a single dose of moclobemide in homozygotic EM genotype for CYP2C19
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Omeprazole hydroxylation is in ...... ygotic EM genotype for CYP2C19
@ast
Omeprazole hydroxylation is in ...... ygotic EM genotype for CYP2C19
@en
type
label
Omeprazole hydroxylation is in ...... ygotic EM genotype for CYP2C19
@ast
Omeprazole hydroxylation is in ...... ygotic EM genotype for CYP2C19
@en
prefLabel
Omeprazole hydroxylation is in ...... ygotic EM genotype for CYP2C19
@ast
Omeprazole hydroxylation is in ...... ygotic EM genotype for CYP2C19
@en
P2093
P2860
P1476
Omeprazole hydroxylation is in ...... ygotic EM genotype for CYP2C19
@en
P2093
Byung-Hwan Yang
In-Jin Jang
Joo-Youn Cho
Kyung-Sang Yu
Sang-Goo Shin
P2860
P304
P356
10.1046/J.1365-2125.2002.01366.X
P407
P577
2002-04-01T00:00:00Z